Table 4.
Standardised incidence ratio (SIR) in all MPN patients compared to the general population. MPN=myeloproliferative neoplasm, CI=confidence interval
| Type of cancer |
SIR | 95 %CI |
|---|---|---|
| All non hematologic | 1.4 | 1.3 - 1.5 |
| Non-melanoma skin cancer | 3.3 | 2.9 - 3.8 |
| Brain | 2.1 | 1.5 - 2.8 |
| Kidney | 2 | 1.5 - 2.7 |
| Endocrine organs | 2 | 1.4 - 2.9 |
| Malignant melanoma | 1.9 | 1.4 - 2.7 |
| Pancreas | 1.3 | 0.9 - 1.9 |
| Lung | 1.3 | 1.1 - 1.6 |
| Head and neck | 1.4 | 1.0 - 2.0 |
| Esophagus and stomach | 1.4 | 1.0 - 1.8 |
| Breast | 1 | 0.8 - 1.2 |
| Prostate | 1.1 | 0.96 - 1.3 |
| Liver and gallbladder | 1.2 | 0.9 - 1.8 |
| Colon, rectum, and anus | 1 | 0.8 - 1.2 |
| Female genital organs | 1.4 | 1.1 - 1.7 |
| Urinary tract excluding kidney | 0.9 | 0.7 - 1.2 |
| Acute myeloid leukemia | 33.9 | 30.1 - 38.1 |
| Lymphoma | 2.1 | 1.7 - 2.6 |
| Multiple myeloma | 1.2 | 0.7 - 1.9 |